Coronavirus Infectious Disease Ontology
770 terms(s) returned
| Term Type: | Record: 651 to 700 of 770 Records | Page: 14 of 16, First Previous Next Last | Show Records Per Page |
- dolichol kinase (human)
- dolichol-phosphate mannosyltransferase subunit 1 (human)
- dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase (human)
- dolichyl-diphosphooligosaccharide--protein glycosyltransferase 48 kDa subunit (human)
- dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 1 (human)
- dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 2 (human)
- dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit DAD1 (human)
- dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit STT3A (human)
- dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit STT3B (human)
- dolichyl-phosphate beta-glucosyltransferase
- dolichyl-phosphate beta-glucosyltransferase (human)
- dolichyldiphosphatase 1 (human)
- donepezil
- donepezil (1+)
- donor
- dopamine metabolic process
- dopamine receptor
- dopamine receptor signaling pathway
- dopamine transport
- dopaminergic agent
- dopaminergic antagonist
- double-strand-break repair protein rad21 homolog (human)
- double-stranded DNA
- double-stranded RNA-binding protein Staufen homolog 1 (human)
- double-stranded RNA-binding protein Staufen homolog 2 (human)
- double-stranded RNA-specific adenosine deaminase (human)
- double-stranded RNA-specific editase 1 (human)
- doublecortin domain-containing protein 2 (human)
- doublecortin-like kinase
- drebrin (human)
- drive-thru COVID-19 testing entity
- droplet nuclei transmission of SARS-CoV-2
- drug
- drug administration
- drug allergen
- drug capsule
- drug cream
- drug effective against virus
- drug effective in vivo against virus
- drug exposure
- drug exposure end date
- drug exposure end datetime
- drug exposure start date
- drug exposure start datetime
- drug exposure stop reason specification
- drug exposure temporal region
- drug exposure verbatim end date
- drug has protein target
- drug has protein target as activator
- drug has protein target as agonist
